TDAM USA’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,590
Closed -$125K 448
2015
Q1
$125K Buy
1,590
+102
+7% +$8.02K 0.01% 393
2014
Q4
$90K Buy
1,488
+250
+20% +$15.1K ﹤0.01% 314
2014
Q3
$53K Buy
1,238
+200
+19% +$8.56K ﹤0.01% 315
2014
Q2
$64K Sell
1,038
-1
-0.1% -$62 ﹤0.01% 321
2014
Q1
$68K Hold
1,039
﹤0.01% 319
2013
Q4
$58K Sell
1,039
-51
-5% -$2.85K ﹤0.01% 307
2013
Q3
$67K Buy
+1,090
New +$67K ﹤0.01% 297